EAU Guidelines: Non-muscle-invasive Bladder Cancer | Uroweb
This overview represents the updated European Association of Urology (EAU) Guidelines for Non-muscle-invasive Bladder Cancer (NMIBC), TaT1 and carcinoma in situ (CIS).
Related Articles
EAU Guidelines on Sexual and Reproductive Health – Uroweb
The EAU Sexual and Reproductive Health Guidelines aim to provide a overview of the aspects relating to sexual and reproductive health in adult males.
How to Register – Baltic24
Registration for the 9th Baltic Meeting (Baltic24) is open. Register now and benefit from early fee.
EPIDEMIOLOGY AETIOLOGY AND PATHOLOGY – Uroweb
The European Association of Urology (EAU) NMIBC Guidelines Panel has compiled these clinical guidelines to provide urologists with evidence-based information and recommendations for the management…
EAU Guidelines on Urological Trauma – UROGENITAL TRAUMA GUIDELINES – Uroweb
The European Association of Urology (EAU) Guidelines Panel for Urological Trauma have prepared these guidelines in order to assist medical professionals in the management of…
EAU Guidelines on Prostate Cancer – DIAGNOSTIC EVALUATION – Uroweb
The Prostate Cancer (PCa) Guidelines Panel have prepared this guidelines document to assist medical professionals in the evidence-based management of PCa.
Abstracts – ERUS24
You can submit your abstract(s) for ERUS24 online through the online abstract submission website. available from 1 March 2024. The deadline for abstract submission is…
How Long Should Active Surveillance Last?
Men with low-risk prostate cancer who go on active surveillance rather than treatment are best followed-up for more than 15 years — and perhaps indefinitely…
DISEASE MANAGEMENT – Uroweb
This overview represents the updated European Association of Urology (EAU) Guidelines for Non-muscle-invasive Bladder Cancer (NMIBC)
Upper urinary uract Urothelial Cell Carcinoma: New EAU Guidelines update – Uroweb
In this special edition of EAU Podcasts, experts Prof. Paolo Gontero and Prof. Alexandra Masson-Lecomte met in person at the EAU Annual Congress (EAU24) to…
Oral vaccine prevents recurring UTIs for nine years
An oral vaccine in the form of a pineapple-flavoured spray prevented recurrent urinary tract infections in 53.9 per cent of clinical trial participants